The Latest in Lymphoma & Plasma Cell Disorders

Two immunologists receive Nobel Prize in medicine

October 1, 2018

Brentuximab improves survival in older HL patients

October 1, 2018

FDA lifts partial hold on tazemetostat trials

September 26, 2018

FDA approves duvelisib for CLL/SLL and FL

September 25, 2018

Drug approved as part of frontline therapy for HL

September 25, 2018

CHMP backs proposed biosimilars of pegfilgrastim

September 24, 2018

CHMP supports new indication for venetoclax

September 23, 2018

CHMP recommends mogamulizumab for MF, SS

September 22, 2018

CK and TP53 status should be assessed together, team says

September 21, 2018

Stress linked to disease markers in CLL

September 20, 2018

NICE rejects DLBCL indication for CAR T-cell therapy

September 20, 2018

Guidelines for proton therapy in mediastinal lymphomas

September 19, 2018

Risks of watchful waiting in follicular lymphoma

September 19, 2018

ASCO addresses financial barriers to cancer clinical trials

September 18, 2018

FDA approves drug for hairy cell leukemia

September 14, 2018